Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: James Seagrove who wrote (125518)	11/30/2016 7:29:14 PM
From: abuelita	Read Replies (1) \| Respond to of 219459

you can suggest all you like but you are talking through your hat.

To: James Seagrove who wrote (125518)	11/30/2016 10:27:47 PM
From: louel	1 Recommendation Recommended By see clearly now Read Replies (2) \| Respond to of 219459

You are so mis informed like many blind and biased Americans who never see any thing past their own front gate. In reallity Canada ranks higher in Health care than the US. But shamefully neither rank even in the top 25 in the World. thepatientfactor.com Canadian governments spend money on the people with subsidized medical and Education Instead of spending it on the military. Over 9% of the Canadian economy is healthcare and research laboratories. Canadian discoveries are used world wide. such as the Polio Vaccine, AIDS drug 3TC used World wide , Mustard operation that saves the lives of Blue Babies. Insulin which allows people to live with Type 1 diabetes . Vaccine, NeisVac-C, which protects people of all ages against meningococcal meningitis, The 2011 discovery of a treatment of Melanoma with 94% late stage cure rate. innovativemedicines.ca Hardly a third world medical approach ! Canadian governments spend their money on the people with subsidized medical and Education Resulting in having the world's highest educated citizens. Over 51 % of Canadians have college and University degrees. Fortunately for many Americans living close to the Border they come to Canada and are able to purchase drugs they cannot afford in their own country. Again you show your lack of understanding in medicine manufacture. Generic drugs are the same formulas as the original they were copied from. They are simply produced after the patent protection term expires. Example: Aspirin Vs ASA tablets. Or Advil Vs Ibuprofin Pfizer who produces penicillin, Themselves produce Pfizerpen & Pfizerpen-AS A generic copy of their own product sold without the patented branding. Cheers

To: James Seagrove who wrote (125518)	12/1/2016 1:40:00 AM
From: Elroy Jetson	Read Replies (1) \| Respond to of 219459

Based on your comments I have to conclude you've not received medical care in many other industrialized nations. The Doctors and specialists here in and around Beverly Hills are among the best. Far better than you'd find in New York, San Francisco, or other major US cities. But I've received far better medical care in Australia, and all without the dubious ceremony of visiting one of the "loan officers" who validate your insurance coverage. A current ad campaign on American television for Opdivo really highlights many of the defects in our profit driven healthcare industry. America is just about the only place in our planet where you can find advertising of prescription drugs direct to consumers (DTC). It's not legal most places. Designer humanized antibodies sold under names like Opdivo, Keytruda, Yervoy or Rituxan are an important therapy which have been evolving over the past 30 years. They can be designed to attach to cancerous or infected cells to mark them for destruction by your immune system. The results can be amazing and the side-effects often quite minimal. Many were developed at universities like UCLA but brought to the market by major pharma firms. Here in America you'll pay, or someone else will pay on your behalf, $400,000 for a course of treatment with one of these newer antibodies, but 75% less in other countries around the world due to competitive bidding. George W. Bush and Congress specifically prohibited Medicare from competitive bidding for pharmaceutical products - just idiotic. But this is just one part of the problem. Practical experience has shown that an antibody like Opdivo which is 82% effective in treating advanced Hodgkins Lymphoma, and approved for that indication, can also treat many other types of advanced cancers with various degrees of success. A firm like Bristol-Myers-Squibb doesn't need to advertise Opdivo for most cancers because it's very effective so these products sell themselves. Bristol-Myers spent money on a study treating a particular type of lung cancer with the Opdivo antibody but found the results were barely measurable. Patients with terminal advanced lung cancer, already horribly ill from prior chemotherapies, lived 3 month longer when given a $400,000 series of treatment with Opdivo antibodies. Some even died early from reactions to Opdivo. Needless to say most Doctors, investors and reasonable people think 3 extra months of extremely ill living to be a bad investment of $400,000. Bristol-Myers-Squibb lost $20 billion in share price after this failure was reported. So Bristol-Myers is spending $150 million a year on television ads promoting Opdivo for this failed use direct to people with terminal lung cancer - promising them more life (12 weeks to be specific), when other drugs provide more benefit ! Watch the TV ad: ispot.tv I'm not proud of this system of healthcare. It's disgusting. This is an investor update. How much does this sound like a caring medical provider? Bristol-Myers Squibb plans to spend more money on direct-to-consumer advertising for its immuno-oncology drug, Opdivo, company executives told investors during a first-quarter earnings call. BMS CFO Charles Bancroft said the drugmaker was increasing its guidance for marketing, selling and administrative expenses to reflect additional DTC spend. In an investor note, Evercore ISI analyst Mark Schoenebaum played down the possibility of a significant commercial investment, however, saying that the company has already indicated that it believes it is appropriately commercialized for upcoming indication expansions. The drug maker kicked off the DTC campaign, Longer Life, for Opdivo in late September. The advertisement showed the benefits of Opdivo as light cast on buildings, showcasing the drug's benefits, like survival advantage compared to chemotherapy. It's one of only a few cancer drugs to be advertised in this format. BMS CEO Giovanni Caforio has defended the use of direct-to-consumer advertising for a drug only approved for the second-line setting, saying, “there is pessimism for many patients...and a number of patients — particularly in the second-line — are not being treated as effectively as they should [be].” Opdivo saw sales of $704 million for the first quarter of 2015, up 48% from last quarter, beating analyst consensus estimates of $587 million. The DTC campaign launched during the company's fourth quarter of 2015.